>>20974891 lb ;)
PlaneFaggin’:Left Coast style-AWACS, Rivet Joint and tankers S from Nellis heading off shore
SENTRY50 E3 AWACS, CORVS55 Rivet Joint with 3 tankers: DNSTY12 KC-46A with 62-3554 and 58-0133 KC-135 and an Aussie AF MGPE01 E7 Wedgetail out of Nellis heading south off Baja
Avalon Ventures XI, L.P. Sold $82.125m of Janux Theraputics-June 5th
Janux Therapeutics
Janux Therapeutics is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer. Janux’s initial focus is on developing a novel class of T cell engagers (TCEs), and its lead product candidates are designed to target clinically validated drug targets. While TCE therapeutics have displayed potent anti-tumor activity in hematological cancers, developing TCEs to treat solid tumors have faced challenges due to the limitations of prior TCE technologies, namely (i) overactivation of the immune system leading to cytokine release syndrome, (ii) on-target, healthy tissue toxicities, and (iii) poor pharmacokinetics leading to short half-life. Janux is using its TRACTr platform technology to engineer product candidates designed to overcome these limitations
https://www.linkedin.com/company/janux-therapeutics
Avalon Ventures
Avalon’s long-standing and successful focus has been on seed and early stage companies, including many it formed in the life science and information technology sectors.  We believe this is the most challenging and rewarding period of company creation – we are former entrepreneurs driven by passionate people pursuing disruptive ideas in ever changing market environments.
https://www.avalon-ventures.com/about
Avalon Ventures Founder
Kevin Kinsella is the founder of Avalon Ventures. He has specialized in the formation, financing and development of more than 125 early-stage companies, including: Athena Neurosciences Onyx Pharmaceuticals, Inc. [ONXX]; Sequana, Vertex Pharmaceuticals [VRTX], Synaptics [SYNA], Vocera Communications [VCRA], Amira Pharmaceuticals (acquired by BMS), AnaptysBio, JNANA and Eikonizo. Mr. Kinsella was the founding chairman of Athena Neurosciences, Aurora Biosciences, Landmark Graphics, NeoRx, Onyx Pharmaceuticals, Synaptics, Vertex Pharmaceuticals, X-Ceptor and Sequana Therapeutics.
Prior to founding Avalon, Mr. Kinsella worked for Solar Turbines International (Caterpillar Tractor) where he directed all international joint ventures, barter and counter-trade. Previously, he was an advisor to the Peruvian government in National Nutrition Planning where he developed the first commercialization plan for Quinoa; ran a technology exchange program between the U.S. and Latin America based in Mexico City; and, taught algebra at the American High School in Beirut, Lebanon. He was also a guest op-ed columnist for the Boston Herald American.
Mr. Kinsella is a member of the Council on Foreign Relations.
https://www.avalon-ventures.com/bios/kevin-kinsella
https://finviz.com/insidertrading.ashx?oc=1652901&tc=7&b=2
Would be moar if people like this >>20975470 didn’t complain all the fuckin’ time
It’s intimidating for some
SPAR15 C40C arriving at Cherbourg Airport, France from JBA depart
SPAR=Special Priority Air Resource
On this day in history, June 6, 1944-Commemorating the 80th anniversary of the D-Day invasion
The June 6, 1944, D-Day invasion of Nazi-occupied France was unprecedented in scale and audacity, using the largest-ever armada of ships, troops, planes and vehicles to punch a hole in Adolf Hitler’s defenses in western Europe and change the course of World War II.
The 80th anniversary of the Normandy invasion is Thursday, and with it comes commemorations on the beaches of France where allied troops landed. D-Day veterans and other dignitaries will gather to remember the thousands of lives lost during the invasion, but they will also remember the lives they saved.
https://www.chicagotribune.com/2024/06/05/commemorating-the-80th-anniversary-of-the-d-day-invasion/